Chenyang Shi, Jiaxin Li, Guorong Fan, & Yu Liu. (2022). Blocking CD47 Shows Superior Anti-tumor Therapeutic Effects of Bevacizumab in Gastric Cancer. Frontiers Media S.A..
Chicago Style (17th ed.) CitationChenyang Shi, Jiaxin Li, Guorong Fan, and Yu Liu. Blocking CD47 Shows Superior Anti-tumor Therapeutic Effects of Bevacizumab in Gastric Cancer. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationChenyang Shi, et al. Blocking CD47 Shows Superior Anti-tumor Therapeutic Effects of Bevacizumab in Gastric Cancer. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.